Citation Impact
Citing Papers
A First-in-Human, Phase I, Dose-Escalation Study of TAK-117, a Selective PI3Kα Isoform Inhibitor, in Patients with Advanced Solid Malignancies
2017
Wnt5a Suppresses Epithelial Ovarian Cancer by Promoting Cellular Senescence
2011
Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer
1999 Standout
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
2009 Standout
Expression of p53, transforming growth factor alpha, epidermal growth factor receptor, and c-erbB-2 in endometrial carcinoma and correlation with survival and known predictors of survival
1994
Amplification of Tissue by Construction of Tissue Microarrays
2001
TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use
2009 Standout
A view on drug resistance in cancer
2019 StandoutNature
Adenocarcinomas Arising from Uterine Adenomyosis: A Report of Four Cases
2002 StandoutNobel
Suppression of Nucleotide Metabolism Underlies the Establishment and Maintenance of Oncogene-Induced Senescence
2013
Contribution of platelets to tumour metastasis
2011 Standout
p53 overexpression in advanced-stage endometrial adenocarcinoma
1996
Neonatal estrogenic exposure suppresses PTEN-related endometrial carcinogenesis in recombinant mice
2006 StandoutNobel
IL-6 Secreted from Cancer-Associated Fibroblasts Mediates Chemoresistance in NSCLC by Increasing Epithelial-Mesenchymal Transition Signaling
2016
WNT signalling pathways as therapeutic targets in cancer
2012 Standout
Identification of ribonucleotide reductase M2 as a potential target for pro-senescence therapy in epithelial ovarian cancer
2013
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck Cancers
2000 Standout
Prognostic significance of thrombocytosis in patients with primary lung cancer
1996
Estrogen Receptors in Human Nontarget Tissues: Biological and Clinical Implications*
1995
Multi-targeted therapy of cancer by genistein
2008 Standout
The effect of peripheral blood values on prognosis of patients with locally advanced gastric cancer before treatment
2009
ADP activation induces bFGF binding to platelets in vitro
2002 StandoutNobel
p53Mutations and Presence of HPV DNA Do Not Correlate with Radiosensitivity of Gynecological Cancer Cell Lines
1998
A metabolic labeling approach for glycoproteomic analysis reveals altered glycoprotein expression upon GALNT3 knockdown in ovarian cancer cells
2016 StandoutNobel
The prognostic value of immunohistochemical estrogen receptor analysis in paraffin-embedded and frozen sections versus that of steroid-binding assays
1990
Understanding the Intersections between Metabolism and Cancer Biology
2017 Standout
The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer
2013 Standout
Molecular basis of agonism and antagonism in the oestrogen receptor
1997 StandoutNature
Technology Insight: identification of biomarkers with tissue microarray technology
2004
The role of senescent cells in ageing
2014 StandoutNature
Oestrogen Receptor Analysis of Paraffin Sections and Cytosol Samples of Primary Breast Cancer in Relation to Outcome After Adjuvant Tamoxifen Treatment
1996
The PI3K Pathway in Human Disease
2017 Standout
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Levels of TGF-α and EGFR Protein in Head and Neck Squamous Cell Carcinoma and Patient Survival
1998 Standout
Endometrial Glandular Dysplasia with Frequent p53 Gene Mutation: A Genetic Evidence Supporting Its Precancer Nature for Endometrial Serous Carcinoma
2008
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
1999 Standout
Immunocytochemical analysis of estrogen receptors as a predictor of prognosis in breast cancer patients: comparison with quantitative biochemical methods.
1989
Impact of pretreatment thrombocytosis on survival in primary breast cancer
2003
Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600–Mutant Colorectal Cancer
2015
The frequency of p53, k-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma
2000
Platelet count and survival in patients with colorectal cancer--a preliminary study.
1998
PTEN mutation in endometrial cancers is associated with favorable clinical and pathologic characteristics.
1998
X-Tile
2004 Standout
High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/- mice.
2000 StandoutNobel
Works of Soper Jt being referenced
Overexpression and mutation of p53 in endometrial carcinoma.
1992
The negative prognostic implications of thrombocytosis in women with stage IB cervical cancer.
1994
Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors.
1986